Joke Regts
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Lipid Membrane Structure and Behavior 12
- Epidemiology 14
- Hepatitis B Virus Studies 6
- Herpesvirus Infections and Treatments 6
- Co-authors
- Gerrit L. Scherphof (17 shared papers)Jan Wilschut (17 shared papers)Jan Damen (3 shared papers)Toos Daemen (21 shared papers)Frits H. Roerdink (5 shared papers)Annelies Riezebos‐Brilman (6 shared papers)Bert Dontje (4 shared papers)Laura Bungener (3 shared papers)
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (8 papers)Gene Therapy (5 papers)Vaccine (4 papers)FEBS Letters (3 papers)Antiviral Therapy (2 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Joke Regts
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Biomaterials 267
- Immunology 340
- Biochemistry 101
- Molecular Biology 677
- Hepatology 64
Countries citing papers authored by Joke Regts
This map shows the geographic impact of Joke Regts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Regts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Regts more than expected).
Fields of papers citing papers by Joke Regts
This network shows the impact of papers produced by Joke Regts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Regts. The network helps show where Joke Regts may publish in the future.
Co-authors
The 25 scholars most cited alongside Joke Regts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 136 | |
| 2 | 1981 | 134 | |
| 3 | 1978 | 107 | |
| 4 | 1986 | 73 | |
| 5 | 1999 | 70 | |
| 6 | 1997 | 70 | |
| 7 | 2003 | 65 | |
| 8 | 1984 | 64 | |
| 9 | 2004 | 58 | |
| 10 | 2002 | 54 | |
| 11 | 1997 | 54 | |
| 12 | 1997 | 47 | |
| 13 | 2000 | 39 | |
| 14 | 1979 | 39 | |
| 15 | 2005 | 33 | |
| 16 | 1979 | 32 | |
| 17 | 1989 | 29 | |
| 18 | 2007 | 28 | |
| 19 | 2013 | 27 | |
| 20 | 1980 | 27 |
About Joke Regts
Joke Regts is a scholar working on Molecular Biology, Epidemiology, Immunology, Oncology and Physiology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (12 papers), Immunotherapy and Immune Responses (10 papers), Hepatitis B Virus Studies (6 papers), Herpesvirus Infections and Treatments (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Biomedical Research and Pathophysiology (3 papers), Viral Infections and Outbreaks Research (3 papers) and Erythrocyte Function and Pathophysiology (3 papers). The work is most often cited by research in Biomaterials (267 citations), Immunology (340 citations), Biochemistry (101 citations), Molecular Biology (677 citations) and Hepatology (64 citations). Joke Regts has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Gerrit L. Scherphof, Jan Wilschut, Jan Damen, Toos Daemen, Frits H. Roerdink, Annelies Riezebos‐Brilman, Bert Dontje, Laura Bungener, Mieke van Galen and Halbe H. Spanjer. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Gene Therapy, Vaccine, FEBS Letters and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.